Yihan Wang is the founder of Shenzhen TargetRx. Shenzhen TargetRx has raised $50M in total funding. Based in Shenzhen, China.
Yihan Wang is the Founder and CEO of Shenzhen TargetRx, a Sino-American joint venture specializing in high-tech pharmaceutical research and development. The company focuses on the research and development of targeted drugs, aiming to become a leading platform for these drugs globally. Founded in August 2014, Shenzhen TargetRx received investment from angel institutions in China. Wang, a New York University graduate and an internationally recognized medical expert, has over 16 years of experience in small molecule targeted anti-cancer drugs and is a key inventor of several forefront international drugs.
Full founder directory · Investor directory · Company funding database · Fundraising library